Matches in SemOpenAlex for { <https://semopenalex.org/work/W3214740984> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W3214740984 endingPage "315" @default.
- W3214740984 startingPage "311" @default.
- W3214740984 abstract "As clinicians and patients await consensus on intraovarian platelet-rich plasma (PRP) treatment, this project evaluated contemporary research trends in the literature.A PubMed/NLM search aggregated all ovarian PRP-related publications (n=54) to evaluate their scope, abstract utility, submission-to-publication interval, journal selected, article processing charge (APC), free reader access to full-text manuscripts, number and nationality of authors, and inclusion of international collaborators. The NIH Clinical Trials database was also audited.Published output on intraovarian PRP has increased consistently since 2016, especially among investigators in Greece, Iran, USA, and Turkey. Between 2013 and 2021, 42 articles met the relevancy criteria, of which 40.5% reported clinical studies, small series, or case reports, 33% described experimental animal models, and 23.8% were opinion/review papers. Only two works included a placebo control group. The submission-to-publication interval (mean±standard deviation) was 130±96 days, there were 5.9±3.2 authors per project, and journals invoiced US $1,613±1,466 (range, $0-$3,860) for APCs.There was no correlation between APC and time to publish (Pearson's r=-0.01). Abstract content was inconsistent; sample size and patient age were often missing, yet free full-text open access was available for most publications (59.5%). The NIH Clinical Trials portal lists eight registered studies on ovarian rejuvenation, of which two are actively recruiting patients, while four have been terminated or have an uncertain status. Two studies have concluded, with results from one posted to the NIH website. PRP and its derivatives for ovarian treatment show early promise, but require further investigation. Research is accelerating and should be encouraged, particularly placebo-controlled randomized clinical trials." @default.
- W3214740984 created "2021-12-06" @default.
- W3214740984 creator A5058402960 @default.
- W3214740984 creator A5082049110 @default.
- W3214740984 date "2021-12-01" @default.
- W3214740984 modified "2023-09-25" @default.
- W3214740984 title "Progress in human ovarian rejuvenation: Current platelet-rich plasma and condensed cytokine research activity by scope and international origin" @default.
- W3214740984 cites W2555200452 @default.
- W3214740984 cites W2584778320 @default.
- W3214740984 cites W2992845476 @default.
- W3214740984 cites W3033361750 @default.
- W3214740984 cites W3166472392 @default.
- W3214740984 cites W4240551202 @default.
- W3214740984 doi "https://doi.org/10.5653/cerm.2021.04651" @default.
- W3214740984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34875738" @default.
- W3214740984 hasPublicationYear "2021" @default.
- W3214740984 type Work @default.
- W3214740984 sameAs 3214740984 @default.
- W3214740984 citedByCount "6" @default.
- W3214740984 countsByYear W32147409842022 @default.
- W3214740984 countsByYear W32147409842023 @default.
- W3214740984 crossrefType "journal-article" @default.
- W3214740984 hasAuthorship W3214740984A5058402960 @default.
- W3214740984 hasAuthorship W3214740984A5082049110 @default.
- W3214740984 hasBestOaLocation W32147409841 @default.
- W3214740984 hasConcept C105795698 @default.
- W3214740984 hasConcept C126322002 @default.
- W3214740984 hasConcept C129848803 @default.
- W3214740984 hasConcept C2771230 @default.
- W3214740984 hasConcept C33923547 @default.
- W3214740984 hasConcept C512399662 @default.
- W3214740984 hasConcept C535046627 @default.
- W3214740984 hasConcept C71924100 @default.
- W3214740984 hasConceptScore W3214740984C105795698 @default.
- W3214740984 hasConceptScore W3214740984C126322002 @default.
- W3214740984 hasConceptScore W3214740984C129848803 @default.
- W3214740984 hasConceptScore W3214740984C2771230 @default.
- W3214740984 hasConceptScore W3214740984C33923547 @default.
- W3214740984 hasConceptScore W3214740984C512399662 @default.
- W3214740984 hasConceptScore W3214740984C535046627 @default.
- W3214740984 hasConceptScore W3214740984C71924100 @default.
- W3214740984 hasIssue "4" @default.
- W3214740984 hasLocation W32147409841 @default.
- W3214740984 hasLocation W32147409842 @default.
- W3214740984 hasLocation W32147409843 @default.
- W3214740984 hasOpenAccess W3214740984 @default.
- W3214740984 hasPrimaryLocation W32147409841 @default.
- W3214740984 hasRelatedWork W1587188747 @default.
- W3214740984 hasRelatedWork W2032494946 @default.
- W3214740984 hasRelatedWork W2078188784 @default.
- W3214740984 hasRelatedWork W2115469608 @default.
- W3214740984 hasRelatedWork W2161595156 @default.
- W3214740984 hasRelatedWork W2355676823 @default.
- W3214740984 hasRelatedWork W2382535370 @default.
- W3214740984 hasRelatedWork W3021421529 @default.
- W3214740984 hasRelatedWork W3185650752 @default.
- W3214740984 hasRelatedWork W4290673869 @default.
- W3214740984 hasVolume "48" @default.
- W3214740984 isParatext "false" @default.
- W3214740984 isRetracted "false" @default.
- W3214740984 magId "3214740984" @default.
- W3214740984 workType "article" @default.